ÐÓ°ÉÂÛ̳

Skip to main content
Quest Diagnostics

Associations of Beta-amyloid and Alzheimer¡¯s Disease Risk With Patient Age in Over 2,000 Plasma Specimens Analyzed by LC-MS/MS

Alzheimer¡¯s Association International Conference?

AAIC 2023

Amsterdam, Netherlands and virtual,? July 16 ¨C 20. 2023

Poster presentation:?

Authors:?Weber DM, Kim JC, Goldman SM, Clarke NJ, Racke MK

Specialty:?Neurology

Related content

On-Demand Webinar
Assessing Alzheimer's Disease Risk in Primary Care Settings
On-Demand Webinar
The Emerging Role of Blood-based Biomarkers in Alzheimer's Disease
On-Demand Webinar
Dementia: Prevention, Diagnosis, & Management
Audio Podcast
Assessing for Alzheimer¡¯s Disease with Quest Diagnostics
Audio Podcast
Alzheimer¡¯s Disease: A New Generation of Screenings and Therapies on the Horizon
Audio Podcast
Patient-minded Neurology

Our company

Quest? is the brand name used for services offered by ÐÓ°ÉÂÛ̳ and its affiliated companies. ÐÓ°ÉÂÛ̳ and certain affiliates are CLIA-certified laboratories that provide HIPAA-covered services.? Other affiliates operated under the Quest? brand, such as Quest Consumer Inc., do not provide HIPAA-covered services.?

?

Quest?, Quest Diagnostics?, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks¡ª? and ?¡ªare the property of their respective owners. ? 2025 ÐÓ°ÉÂÛ̳. All rights reserved. Image content features models and is intended for illustrative purposes only.